BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 15297205)

  • 21. Treatment of stage IV "high-grade" endometrial stromal sarcoma with ifosfamide, adriamycin, and cisplatin.
    Yamawaki T; Shimizu Y; Hasumi K
    Gynecol Oncol; 1997 Feb; 64(2):265-9. PubMed ID: 9038274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Occult myometrial recurrence after progesterone therapy to preserve fertility in a young patient with endometrial cancer.
    Hurst SA; Hartzfeld KM; Del Priore G
    Fertil Steril; 2008 Mar; 89(3):724.e1-3. PubMed ID: 17570366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aromatase inhibitor therapy for endometrial stromal sarcoma - two-centre experience.
    Serkies K; Abacjew-Chmyłko A; Wieczorek-Rutkowska M; Pęksa R
    Ginekol Pol; 2018; 89(11):607-610. PubMed ID: 30508212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: single center experience with 10 cases and review of the literature.
    Pink D; Lindner T; Mrozek A; Kretzschmar A; Thuss-Patience PC; Dörken B; Reichardt P
    Gynecol Oncol; 2006 Jun; 101(3):464-9. PubMed ID: 16368128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival in low-grade endometrial stromal sarcoma with childbirth and multidisciplinary treatment: a case report.
    Maeda O; Moritani S; Ichihara S; Inoue T; Ishihara Y; Yamamoto S; Ito M; Matsumura Y; Sugiyama K; Horio M; Kondo I
    J Med Case Rep; 2015 Oct; 9():233. PubMed ID: 26481040
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of late recurrence of a low-grade endometrial stromal sarcoma (LGESS): treatment with letrozole.
    Krauss K; Bachmann C; Hartmann JT; Siegmann K; Sotlar K; Wallwiener D; Huober J
    Anticancer Res; 2007; 27(5B):3477-80. PubMed ID: 17972504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment and prognosis of low-grade malignant endometrial stromal sarcoma].
    Ma SK; Zhang HT; Wu LY; Liu LY; Li B
    Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):74-8. PubMed ID: 17575701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic uterine leiomyosarcoma regression using an aromatase inhibitor.
    Hardman MP; Roman JJ; Burnett AF; Santin AD
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):518-20. PubMed ID: 17666649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The high-grade endometrial sarcoma: a rare entity.
    Lenhard SM; Untch M; Himsl I; Ditsch N; Bittmann I; Friese K; Bauerfeind I
    Arch Gynecol Obstet; 2006 Apr; 274(1):56-9. PubMed ID: 16311750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endometrial stromal sarcoma: a rare entity.
    Jabeen S; Anwar S; Fatima N
    J Coll Physicians Surg Pak; 2015 Mar; 25(3):216-7. PubMed ID: 25772965
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Successful treatment of recurrent endometrial stromal sarcoma by radiotherapy and intra-arterial chemotherapy with CDDP and ADM].
    Kakimoto K; Ando Y
    Gan To Kagaku Ryoho; 1996 Aug; 23(9):1209-12. PubMed ID: 8751813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-grade endometrial stromal sarcoma of the uterus: review of 10 cases.
    Landréat V; Paillocher N; Catala L; Foucher F; Descamps P; Levêque J
    Anticancer Res; 2008; 28(5B):2869-74. PubMed ID: 19031927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrence patterns and prognosis of endometrial stromal sarcoma and the potential of tyrosine kinase-inhibiting therapy.
    Cheng X; Yang G; Schmeler KM; Coleman RL; Tu X; Liu J; Kavanagh JJ
    Gynecol Oncol; 2011 May; 121(2):323-7. PubMed ID: 21277011
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anastrozole, an aromatase inhibitor, and medroxyprogesterone acetate therapy in premenopausal obese women with endometrial cancer: a report of two cases successfully treated without hysterectomy.
    Burnett AF; Bahador A; Amezcua C
    Gynecol Oncol; 2004 Sep; 94(3):832-4. PubMed ID: 15350383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormonal therapy for the management of grade 1 endometrial adenocarcinoma: a literature review.
    Ramirez PT; Frumovitz M; Bodurka DC; Sun CC; Levenback C
    Gynecol Oncol; 2004 Oct; 95(1):133-8. PubMed ID: 15385122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reevaluating the safety of fertility-sparing hormonal therapy for early endometrial cancer.
    Yang YC; Wu CC; Chen CP; Chang CL; Wang KL
    Gynecol Oncol; 2005 Nov; 99(2):287-93. PubMed ID: 16051341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-grade endometrial stromal sarcoma of the ectocervix after therapy for breast cancer.
    Boardman CH; Webb MJ; Jefferies JA
    Gynecol Oncol; 2000 Oct; 79(1):120-3. PubMed ID: 11006043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intracaval extension of a recurrent low-grade endometrial stromal sarcoma.
    Debing E; Van der Niepen P; Goossens A; Van der den Brande P
    Acta Chir Belg; 1998 Dec; 98(6):264-6. PubMed ID: 9922815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recurrent endometrial carcinoma regression with the use of the aromatase inhibitor anastrozole.
    Bellone S; Shah HR; McKenney JK; Stone PJ; Santin AD
    Am J Obstet Gynecol; 2008 Sep; 199(3):e7-e10. PubMed ID: 18550023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful use of dydrogesterone as maintenance therapy in recurrent endometrial stromal sarcoma: a case report.
    Akashi D; Todo Y; Shimada C; Okamoto K; Minobe S; Kato H
    Jpn J Clin Oncol; 2013 Nov; 43(11):1145-9. PubMed ID: 24058200
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.